Results 181 to 190 of about 2,875,336 (355)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium Guidance [PDF]

, 2013

core   +1 more source

Patient Reported Outcome [PDF]

, 2020
openaire   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery – A retrospective cohort study [PDF]

Martin Heidinger, Julie M Loesch, Jeremy Levy, Nadia Maggi, Ruth S Eller, Fabienne D Schwab, Christian Kurzeder, William P. Weber   +7 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Language concordance in the digital collection of patient-reported outcome measures. [PDF]

JAMIA Open
Liu JB, Dacier BM, Dragonetti BM, Meyers PM, Sisodia RC, Park LH, Pusic AL, Ortega G.   +7 more
europepmc   +1 more source

Psychometric properties of patient-reported outcome measures for periacetabular osteotomy [PDF]

, 2019
Clohisy, John C, Pascual-Garrido, Cecilia, Wasko, Marcin K, Yanik, Elizabeth L   +3 more
core   +1 more source

Telehealth in Palliative Care: A Systematic Review of Patient Reported Outcomes

, 2017
A systematic review was conducted to explore published quantitative and qualitative research describing patient-reported outcomes of palliative telehealth intervention studies.
Head, Barbara A., Schapmire, Tara J., Zheng, Yongqiang   +2 more
core  

A case report of spontaneous conception with successful pregnancy outcome in a patient with end-stage chronic renal failure

, 2017
Elie Nkwabong, Nadège Nnang Amougou, Clifford-Ebontane Ebong   +2 more
openalex   +1 more source